BSE · OXYGENTAPH
OXYGENTA PHARMACEUTICAL LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,508
of 5,004 stocks
▼ 351W
Peak #2,473 · 21 Sep 2026
OXYGENTA PHARMACEUTICAL LIMITED is a microcap company in the Healthcare space and trades at an undemanding earnings multiple, generates a high return on equity, and is growing revenue modestly.
Market Cap
178.33 Cr
P/E Ratio
10.15
P/B Ratio
—
ROE
41.16%
ROCE
-51.82%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 37.00 Cr | 49.61 Cr | 33.93 Cr | 14.30 Cr |
| Net Profit | -2.10 Cr | -1.70 Cr | -4.84 Cr | -4.93 Cr |
| EPS | 0.57 | 0.45 | 1.32 | 1.33 |
| Operating Profit | -4.81 L | 52.83 L | -4.94 Cr | -5.49 Cr |
Shareholding pattern
Promoter
56.54%
Public
43.46%
PUBLIC BREAKDOWN
DII
0.03%
MF (within DII)
0.03%
Individuals
42.63%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.